DENVER / May 25, 2023 / Business Wire / Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company released its 2022 Environmental, Social, and Governance (ESG) Report. The annual report provides an update regarding Modivcare’s ESG governance and sustainability efforts, as well as progress made to eliminate inequities in healthcare through its supportive care services focused on the social determinants of health.
“Our annual ESG report illustrates our commitment to provide greater access to healthcare for the country’s most vulnerable populations,” said L. Heath Sampson, President and Chief Executive Officer of Modivcare. “Our supportive care services address the social determinants of health, and we take pride in providing these valuable services to approximately 34 million members through our non-emergency medical transportation (NEMT), personal care, and remote patient monitoring services. We remain committed to enhancing our sustainability and reducing our greenhouse gas emissions, as our ESG report shows a 15% year-over-year reduction in our Scope 1 emissions. Our team continues to make progress with our diversity, equity, and inclusion (DEI) initiatives and we look forward to providing updates as we expand our ESG disclosures and commitments in the future.”
Highlights from Modivcare’s 2022 ESG report:
The ESG report is accessible on Modivcare’s Investor Relations website and can be accessed by clicking this link.
About Modivcare
Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their members. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.
Last Trade: | US$11.13 |
Daily Change: | 0.24 2.20 |
Daily Volume: | 412,581 |
Market Cap: | US$158.940M |
October 23, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB